HAVCR2 and hepatocellular carcinoma: Importantly, blocking of the TIM-3-Gal-9 signaling pathways has been shown to reactivate the T-cell-mediated antitumor immune response, as evidenced by increased cytokine production and T-cell proliferation within the HCC TME [137,147].